INSM FY 2017 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$189M

Net Income

-$193M

EPS (Diluted)

$-2.89

Cash Flow

Operating Cash Flow

-$160M

Free Cash Flow

-$163M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$462M

Total Liabilities

$101M

Stockholders' Equity

$361M

Cash & Equivalents

$381M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$2M	-19.0%
Operating Income	-$189M	-$173M	-9.0%
Net Income	-$193M	-$176M	-9.3%